Fund moves

Gilead Sciences (GILD): Glenview Trust Co added to its stake +7,359 shares

Glenview Trust Co added to its stake in Gilead Sciences, per its Q2 2025 13F.

184K
Shares reported · +7,359 vs prior quarter
0.35%
Disclosed portfolio weight
$20.4M
Reported value
Holdings as of
Jun 30, 2025
Filed
Aug 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
  2. May 12, 2025CongressDisclosed sale of GILD — reported range $15,001 - $50,000
  3. Jun 6, 2025CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
  4. Jun 16, 2025Insider · 2 peopleInsiders: 2 sales (~$606K)
  5. Jun 18, 2025FDAFDA drug approval: Yeztugo
  6. Jun 18, 2025FDAFDA drug approval: Yeztugo
  7. Jun 20, 2025FDAFDA drug approval: Tybost
  8. Jun 20, 2025FDAFDA drug approval: Tybost
  9. Jun 20, 2025FDAFDA drug approval: Descovy
  10. Jun 20, 2025FDAFDA drug approval: Descovy
  11. Jun 30, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
  12. Jul 14, 2025InsiderDirector sold ~$549K of GILD shares in the open market
  13. Jul 15, 2025Insider · 2 peopleInsiders: 2 sales (~$611K)
  14. Jul 28, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
  15. Jul 30, 2025FDAFDA drug approval: Biktarvy
  16. Aug 6, 2025Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 5 employees

What came next

  1. Aug 15, 2025Insider · 2 peopleInsiders: 7 sales (~$3.6M)
  2. Aug 28, 2025InsiderCEO sold ~$1.14M of GILD shares in the open market
  3. Sep 15, 2025Insider · 2 peopleInsiders: 2 sales (~$625K)
  4. Sep 23, 2025CongressDisclosed sale of GILD — reported range $1,001 - $15,000
  5. Sep 29, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
  6. Oct 15, 2025Insider · 2 peopleInsiders: 2 sales (~$649K)
  7. Oct 28, 2025Insider · 1 personInsiders: 2 sales (~$1.2M)
  8. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  9. Nov 12, 2025Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 17 employees
  10. Nov 12, 2025Insider · 1 personInsiders: 3 sales (~$6.6M)
  11. Nov 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 19 , 2025, Gilead Sciences, Inc., a Delaware corporation (the “Company”), announced that Deborah H. Telman will no longer serve as Executive Vice President, Corporate Affairs and General Counsel of the Company as of December 5, 2025.”
  12. Nov 17, 2025Insider · 2 peopleInsiders: 3 sales (~$3.8M)
  13. Nov 26, 2025InsiderDirector sold ~$357K of GILD shares in the open market
  14. Nov 28, 2025Insider · 3 peopleInsiders: 4 sales (~$2.2M)
  15. Dec 12, 2025Government · Federal Register noticeDetermination That DEMEROL (Meperidine Hydrochloride) Tablet, 100 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Gilead Sciences

For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.

How this filing works

Explore the data

Common questions

What does this filing report about Gilead Sciences (GILD) stock?

Glenview Trust Co added to its stake in Gilead Sciences, per its Q2 2025 13F. Now 184K shares, $20.4M reported value, 0.35% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2025. Filed: Aug 14, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Gilead Sciences recently?

For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GILD page.

Does this mean GILD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Gilead Sciences

Everything OQRO holds on this company is on its GILD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data